Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study

PURPOSE: Peripheral T-cell lymphomas (PTCLs) represent a diverse group of non-Hodgkin lymphomas with a poor prognosis and no accepted standard of care for patients with relapsed or refractory disease. This study evaluated the efficacy and tolerability of belinostat, a novel histone deacetylase inhib...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: O'Connor, Owen A., Horwitz, Steven, Masszi, Tamás, Van Hoof, Achiel, Brown, Peter, Doorduijn, Jeannette, Hess, Georg, Jurczak, Wojciech, Knoblauch, Poul, Chawla, Shanta, Bhat, Gajanan, Choi, Mi Rim, Walewski, Jan, Savage, Kerry, Foss, Francine, Allen, Lee F., Shustov, Andrei
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2015
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087312/
https://ncbi.nlm.nih.gov/pubmed/26101246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.2782
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky